Comonte suggested that the filing was supported by lenders, who are committed to helping the company shed its $1.15 billion debt, appeal to new customers, and innovate in the rapidly evolving weight management landscape a space that is currently swamped with competitive GLP-1 solutions
Market Map 6
News, Medical and Life Sciences, Obesity drug codenamed AOD 9604 highly successful in trials, 16 December 2004
Although common, the condition is frequently misdiagnosed, with an estimated prevalence of up to ~ 10% in women [5,6,7]
Always consult with a healthcare professional before starting any new treatment regimen, and ensure that you're obtaining these injections from a reputable, licensed source